Ruifeng Luo
- Molecular Biology
- Genetics top 10%
- Biomaterials top 10%
- Pharmaceutical Science top 2%
- Biomedical Engineering
- Topics
- Inflammatory Bowel Disease (10 papers)Gut microbiota and health (6 papers)Advanced Drug Delivery Systems (6 papers)
- Partner nations
- ChinaMacaoUnited States
In The Last Decade
Ruifeng Luo
37 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 105
- Molecular Biology 434
- Genetics 215
- Biomaterials 186
- Pharmaceutical Science 176
- Biomedical Engineering 176
Countries citing papers authored by Ruifeng Luo
This map shows the geographic impact of Ruifeng Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruifeng Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruifeng Luo more than expected).
Fields of papers citing papers by Ruifeng Luo
This network shows the impact of papers produced by Ruifeng Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruifeng Luo. The network helps show where Ruifeng Luo may publish in the future.
Co-authorship network of co-authors of Ruifeng Luo
This figure shows the co-authorship network connecting the top 25 collaborators of Ruifeng Luo. A scholar is included among the top collaborators of Ruifeng Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruifeng Luo. Ruifeng Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 3 | |
| 7 | 9 | |
| 8 | 7 | |
| 9 | 28 | |
| 10 | 43 | |
| 11 | 5 | |
| 12 | 37 | |
| 13 | 5 | |
| 14 | 48 | |
| 15 | 39 | |
| 16 | 47 | |
| 17 | 36 | |
| 18 | 48 | |
| 19 | 98 | |
| 20 | 15 |
About Ruifeng Luo
Ruifeng Luo is a scholar working on Pharmaceutical Science, Molecular Medicine and Toxicology, having authored 40 papers that have together received 1.2k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (10 papers), Gut microbiota and health (6 papers) and Advanced Drug Delivery Systems (6 papers). The work is most often cited by research in Pharmaceutical Science (176 citations), Molecular Medicine (101 citations) and Complementary and alternative medicine (128 citations). Ruifeng Luo has collaborated with scholars based in China, Macao and United States. Frequent co-authors include Fei Gao, Jinming Zhang, Chaomei Fu, Naijing Ye, Chen Zhang, Haiting Xu, Xiaoqin Han, Wenbiao Nie, Jinfeng Shi and Xiulan Pu. Their work appears in journals such as Advanced Materials, Advanced Functional Materials and Food Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.